Marc Scheineson is quoted on the Food and Drug Administration’s expected approach to regulating CBD.
In the News
May 4, 2022
Inside Health Policy, FDA Week | Woodcock to Chair FDA’s Cannabis Council as It Implements Data Plan
Media Contact